Cognition Disorders Completed Phase 4 Trials for Ginkgo biloba (DB01381)

IndicationStatusPhase
DBCOND0027877 (Cognition Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00042172Treatment for Early Memory LossTreatment